Delivery Order SPE2DB25D3020-SPE2DB25FWKPD
- Not listed
- The Defense Logistics Agency awarded a $12,414.44 firm fixed price delivery order to AmerisourceBergen Drug Corp for 10,000 units/mL of Procrit (epoetin alfa), a medication used to treat anemia. The order was placed on September 4, 2025, with an ultimate completion date of September 5, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting AmerisourceBergen's qualification to meet federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 10,000 units/mL of Procrit (epoetin alfa), a recombinant erythropoietin used to treat anemia, particularly in military healthcare settings. This firm fixed-price delivery order, valued at $2,296.93, was competitively awarded without a set-aside designation and is scheduled for completion by August 4, 2025. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $18,671.66 to AmerisourceBergen Drug Corp for 10,000 units/mL of Procrit, a pharmaceutical product used to treat anemia. The contract is a firm fixed price delivery order with an ultimate completion date of September 10, 2025, and was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- This delivery order, valued at $1,148.21, awards Amerisourcebergen Drug Corp the supply of Procrit 40,000 units/ml vials under a firm fixed price contract with the Defense Logistics Agency (DLA). The award was made on August 7, 2025, with an ultimate completion date of August 8, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. This non-set-aside contract represents a competitive award to the pharmaceutical distributor for a critical injectable...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $3,609.34 firm fixed-price delivery order is for the supply of 40,000 units/mL of the pharmaceutical product PROCRIT. The contract has an ultimate completion date of April 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not set aside, has a ceiling value of $9,477.16 and a completion date of June 25, 2025. Amerisourcebergen is delivering 20,000 units/mL of PROCRIT, a medication used to treat anemia, under a firm fixed-price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
- This contract was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $2,575.16 firm-fixed-price delivery order is for the supply of 10,000 units/ml vials of PROCRIT, a medication, with an ultimate completion date of April 22, 2024. The contract is not associated with a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger $999,999,999.00...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,348.46 contract is for the supply of 20,000 units of the medication PROCRIT (2 mL vials) with a completion date of May 19, 2025. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $5,666.43 contract is for the delivery of 40,000 units/mL vials of the pharmaceutical product PROCRIT. The delivery order has a completion date of January 24, 2024 and was awarded on January 23, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp, through its Corporate Office division,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,542.20 fixed-price delivery order is for the procurement of 40,000 units of the drug Procrit with a strength of 40,000 units/mL. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWKPDDelivery Order
The Defense Logistics Agency awarded a $3,881.47 firm fixed price delivery order to AmerisourceBergen Drug Corp for 40,000 units/mL of Procrit (epoetin alfa), a pharmaceutical used to treat anemia. The award, issued on September 12, 2025, is a non-set-aside competitive contract with an ultimate completion date of September 15, 2025, and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant prime IDC valued at $999,999,999.00 and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The company's federal contract portfolio demonstrates extensive experience fulfilling DLA medical supply requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical devices for Defense Health Agency and U.S. Coast Guard customers. This delivery order aligns with the company's established role as a critical vendor within the federal medical procurement system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 9/12/25 |